Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleos(t)ide analogs therapy.

@article{Wang2019PerformanceOS,
  title={Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleos(t)ide analogs therapy.},
  author={Meng-Lan Wang and Rong Deng and Enqiang Chen and Chuan-Min Tao and Juan Liao and Tao-you Zhou and Juan Wang and Hong Tang},
  journal={Clinics and research in hepatology and gastroenterology},
  year={2019},
  volume={43 3},
  pages={
          301-309
        }
}
AIM This study aimed to investigate long-term kinetics of serum hepatitis B core-related antigen (HBcrAg) and its correlation with serum hepatitis B surface antigen (HBsAg) in a real-world cohort of patients who had received over 8 years of nucleos(t)ide analogs(NAs) therapy. METHODS This was a retrospective study. All patients were recruited from our previous published study, who started therapy with NAs between 2007 and 2008. Serum HBcrAg and HBsAg levels were quantitatively measured at… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.